Učitavanje...
Role of chemotherapy and targeted therapy in early-stage non-small cell lung cancer
INTRODUCTION: Adjuvant platinum based chemotherapy is accepted as standard of care in stage II and III non-small cell lung cancer (NSCLC) patients and is often considered in patients with stage IB disease who have tumors ≥ 4 cm. The survival advantage is modest with approximately 5% at 5 years. AREA...
Spremljeno u:
| Izdano u: | Expert Rev Anticancer Ther |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2017
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6863145/ https://ncbi.nlm.nih.gov/pubmed/29168933 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14737140.2018.1409624 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|